Diagnosis and treatment of multiple sclerosis: a review MP McGinley, CH Goldschmidt, AD Rae-Grant Jama 325 (8), 765-779, 2021 | 772 | 2021 |
Older adults exhibit more intracortical inhibition and less intracortical facilitation than young adults M McGinley, RL Hoffman, DW Russ, JS Thomas, BC Clark Experimental gerontology 45 (9), 671-678, 2010 | 228 | 2010 |
Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions MP McGinley, JA Cohen The Lancet 398 (10306), 1184-1194, 2021 | 174 | 2021 |
Multiple sclerosis management during the COVID-19 pandemic BP Moss, KR Mahajan, RA Bermel, K Hellisz, LH Hua, T Hudec, S Husak, ... Multiple Sclerosis Journal 26 (10), 1163-1171, 2020 | 82 | 2020 |
Advances in the treatment of multiple sclerosis C Goldschmidt, MP McGinley Neurologic clinics 39 (1), 21-33, 2021 | 58 | 2021 |
Teleneurology as a solution for outpatient care during the COVID-19 pandemic MP McGinley, D Ontaneda, Z Wang, M Weber, S Shook, M Stanton, ... Telemedicine and e-Health 26 (12), 1537-1539, 2020 | 44 | 2020 |
Safety of monoclonal antibodies for the treatment of multiple sclerosis MP McGinley, BP Moss, JA Cohen Expert opinion on drug safety 16 (1), 89-100, 2017 | 41 | 2017 |
Implementation and patient experience of outpatient teleneurology L Ross, J Bena, R Bermel, L McCarter, Z Ahmed, H Goforth, N Cherian, ... Telemedicine and e-Health 27 (3), 323-329, 2021 | 38 | 2021 |
Cognitive processing speed in multiple sclerosis clinical practice: association with patient‐reported outcomes, employment and magnetic resonance imaging metrics G Macaron, LE Baldassari, K Nakamura, SM Rao, MP McGinley, BP Moss, ... European Journal of Neurology 27 (7), 1238-1249, 2020 | 35 | 2020 |
Multiple sclerosis performance test: validation of self‐administered neuroperformance modules SM Rao, R Galioto, M Sokolowski, M McGinley, J Freiburger, M Weber, ... European Journal of Neurology 27 (5), 878-886, 2020 | 35 | 2020 |
Bringing the HEET: the argument for high-efficacy early treatment for pediatric-onset multiple sclerosis M McGinley, IT Rossman Neurotherapeutics 14 (4), 985-998, 2017 | 26 | 2017 |
Bridging the gap in epilepsy care: A single‐center experience of 3700 outpatient tele‐epilepsy visits JR Fesler, S Stanton, K Merner, L Ross, MP McGinley, J Bena, ... Epilepsia 61 (8), e95-e100, 2020 | 25 | 2020 |
Expanded access to multiple sclerosis teleneurology care following the COVID-19 pandemic MP McGinley, S Gales, W Rowles, Z Wang, WY Hsu, L Amezcua, R Bove Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (1 …, 2021 | 23 | 2021 |
Perspectives of individuals with multiple sclerosis on discontinuation of disease-modifying therapies MP McGinley, PA Cola, RJ Fox, JA Cohen, JJ Corboy, D Miller Multiple Sclerosis Journal 26 (12), 1581-1589, 2020 | 19 | 2020 |
Technology-enabled assessments to enhance multiple sclerosis clinical care and research G Macaron, BP Moss, H Li, LE Baldassari, SM Rao, D Schindler, ... Neurology: Clinical Practice 10 (3), 222-231, 2020 | 17 | 2020 |
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series J Lambe, MP McGinley, BP Moss, Y Mao-Draayer, R Kassa, JR Ciotti, ... Journal of Neuroimmunology 370, 577933, 2022 | 16 | 2022 |
Technology-enabled comprehensive characterization of multiple sclerosis in clinical practice LE Baldassari, K Nakamura, BP Moss, G Macaron, H Li, M Weber, ... Multiple sclerosis and related disorders 38, 101525, 2020 | 16 | 2020 |
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHS CM Hersh, B Kieseier, C Moor, DM Miller, D Campagnolo, JR Williams, ... Multiple Sclerosis Journal–Experimental, Translational and Clinical 7 (2 …, 2021 | 13 | 2021 |
Providing person-centered care via telemedicine in the era of COVID-19 in multiple sclerosis JR Abbatemarco, J Hartman, M McGinley, RA Bermel, A Boissy, ... Journal of Patient Experience 8, 2374373520981474, 2021 | 13 | 2021 |
Use of a Smartphone to Gather Parkinson’s Disease Neurological Vital Signs during the COVID‐19 Pandemic JL Alberts, MM Koop, MP McGinley, AL Penko, HH Fernandez, S Shook, ... Parkinson’s Disease 2021 (1), 5534282, 2021 | 13 | 2021 |